TABLE 2.
Characteristic or Measure |
Active ABMT Group (N=43) |
Placebo ABMT Group (N=42) |
||
---|---|---|---|---|
N | % | N | % | |
Female | 26 | 60.5 | 24 | 57.1 |
Mean | SD | Mean | SD | |
Age (years) | 11.62 | 2.78 | 11.79 | 2.73 |
IQ | 110.42 | 14.66 | 114.00 | 15.50 |
PARS rating | ||||
Pretreatment assessment | 17.03 | 2.56 | 16.84 | 3.03 |
Midtreatment assessment | 15.26 | 3.86 | 15.38 | 2.85 |
Posttreatment assessmentb | 11.97 | 4.69 | 13.67 | 3.25 |
CGI-I | ||||
Midtreatment assessment | 3.86 | 0.80 | 4.23 | 0.69 |
Posttreatment assessment | 3.35 | 0.88 | 3.29 | 0.97 |
ABMT=attention bias modification therapy; PARS=Pediatric Anxiety Rating Scale; CGI-I=Clinical Global Impressions improvement scale.
Significant difference between groups, p<0.05.